Clinical aspects of MuSK antibody positive seronegative MG

被引:302
作者
Sanders, DB
El-Salem, K
Massey, JM
McConville, J
Vincent, A
机构
[1] Duke Univ, Med Ctr, Div Neurol, Durham, NC 27710 USA
[2] Jordan Univ Sci & Technol, Dept Neurol, Irbid, Jordan
[3] Royal Victoria Hosp, Dept Neurol, Belfast BT12 6BA, Antrim, North Ireland
[4] Weatherall Inst Mol Med, Neurosci Grp, Oxford, England
关键词
D O I
10.1212/01.WNL.0000065882.63904.53
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Serum antibodies to muscle- specific receptor tyrosine kinase were detected in 12 of 32 patients with generalized seronegative MG. All were women, with onset between ages 21 and 59 years. Seven had prominent neck, shoulder, or respiratory muscle weakness and little or delayed ocular muscle involvement. The response to cholinesterase inhibitors was variable, and electromyographic findings suggested myopathy in several. None improved after thymectomy. All patients improved after plasma exchange, and most had a good response to selected immunotherapy. MuSK antibody status should help diagnose MG with atypical presentations and ensure appropriate patient treatment.
引用
收藏
页码:1978 / 1980
页数:3
相关论文
共 8 条
[1]   SERONEGATIVE MYASTHENIA-GRAVIS - CLINICAL-FEATURES, RESPONSE TO THERAPY AND SYNTHESIS OF ACETYLCHOLINE-RECEPTOR ANTIBODIES INVITRO [J].
BIRMANNS, B ;
BRENNER, T ;
ABRAMSKY, O ;
STEINER, I .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1991, 102 (02) :184-189
[2]   Clinical heterogeneity of seronegative myasthenia gravis [J].
Evoli, A ;
Batocchi, AP ;
LoMonaco, M ;
Servidei, S ;
Padua, L ;
Majolini, L ;
Tonali, P .
NEUROMUSCULAR DISORDERS, 1996, 6 (03) :155-161
[3]   Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies [J].
Hoch, W ;
McConville, J ;
Helms, S ;
Newsom-Davis, J ;
Melms, A ;
Vincent, A .
NATURE MEDICINE, 2001, 7 (03) :365-368
[4]   Myasthenia gravis - Recommendations for clinical research standards [J].
Jaretzki, A ;
Barohn, RJ ;
Ernstoff, RM ;
Kaminski, HJ ;
Keesey, JC ;
Penn, AS ;
Sanders, DB .
NEUROLOGY, 2000, 55 (01) :16-23
[5]   The agrin/muscle-specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junction [J].
Liyanage, Y ;
Hoch, W ;
Beeson, D ;
Vincent, A .
MUSCLE & NERVE, 2002, 25 (01) :4-16
[6]  
MOSSMAN S, 1986, LANCET, V1, P116
[7]  
Sanders Donald B., 1997, Neurology, V48, pS40
[8]   Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement [J].
Scuderi, F ;
Marino, M ;
Colonna, L ;
Mannella, F ;
Evoli, A ;
Provenzano, C ;
Bartoccioni, E .
LABORATORY INVESTIGATION, 2002, 82 (09) :1139-1146